Lifeward (LFWD) Liabilities and Shareholders Equity (2013 - 2026)
Lifeward recorded quarterly Liabilities and Shareholders Equity of $33.4 million in Q1 2026, up 45.93% quarter-over-quarter from $22.9 million in Q4 2025, and up 16.0% year-over-year from $28.8 million in Q1 2025.
Lifeward's Liabilities and Shareholders Equity history runs 14 years deep, the most recent figure standing at $33.4 million for Q1 2026.
- In Q1 2026, Liabilities and Shareholders Equity rose 16.0% year-over-year to $33.4 million; the TTM figure through Mar 2026 stood at $106.3 million (down 31.9% YoY), while the FY2025 annual figure was $22.9 million, down 24.89% from the prior year.
- Liabilities and Shareholders Equity came in at $33.4 million for Q1 2026 at Lifeward, up from $22.9 million in the prior quarter.
- In the past five years, Liabilities and Shareholders Equity ranged from a high of $90.0 million in Q1 2022 to a low of $22.9 million in Q4 2025.
- A 5-year average of $53.9 million and a median of $55.2 million in 2024 frame the typical range for Liabilities and Shareholders Equity.
- Across the five-year window, Liabilities and Shareholders Equity increased 20.7% in 2022 and tumbled 51.75% in 2024, its largest moves.
- Lifeward's Liabilities and Shareholders Equity stood at $74.2 million in 2022, then fell by 14.88% to $63.2 million in 2023, then tumbled by 51.75% to $30.5 million in 2024, then dropped by 24.89% to $22.9 million in 2025, then soared by 45.93% to $33.4 million in 2026.
- According to Business Quant data, Liabilities and Shareholders Equity over the past three periods registered $33.4 million, $22.9 million, and $23.2 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Liabilities and Shareholders Equity (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | 110.43 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | 46.29 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | 91.49 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | 44.35 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | 13.32 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 31.92 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | 6.63 Bn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | 37.13 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | 10.74 Bn |
| 10 | Lifeward | 5.59 Mn | -5.81 Mn | 1.34 Mn | 33.42 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 33.42 Mn |
| Dec 31, 2025 | 22.90 Mn |
| Sep 30, 2025 | 23.17 Mn |
| Jun 30, 2025 | 26.78 Mn |
| Mar 31, 2025 | 28.81 Mn |
| Dec 31, 2024 | 30.49 Mn |
| Sep 30, 2024 | 45.77 Mn |
| Jun 30, 2024 | 50.98 Mn |
| Mar 31, 2024 | 55.22 Mn |
| Dec 31, 2023 | 63.19 Mn |
| Sep 30, 2023 | 69.22 Mn |
| Jun 30, 2023 | 65.81 Mn |
| Mar 31, 2023 | 68.98 Mn |
| Dec 31, 2022 | 74.24 Mn |
| Sep 30, 2022 | 80.77 Mn |
| Jun 30, 2022 | 85.80 Mn |
| Mar 31, 2022 | 90.00 Mn |
| Dec 31, 2021 | 94.75 Mn |
| Sep 30, 2021 | 98.72 Mn |
| Jun 30, 2021 | 71.71 Mn |
| Mar 31, 2021 | 74.56 Mn |
| Dec 31, 2020 | 28.07 Mn |
| Sep 30, 2020 | 26.23 Mn |
| Jun 30, 2020 | 22.71 Mn |
| Mar 31, 2020 | 25.22 Mn |
| Dec 31, 2019 | 24.37 Mn |
| Sep 30, 2019 | 28.43 Mn |
| Jun 30, 2019 | 31.97 Mn |
| Mar 31, 2019 | 17.04 Mn |
| Dec 31, 2018 | 14.96 Mn |
| Sep 30, 2018 | 11.87 Mn |
| Jun 30, 2018 | 17.03 Mn |
| Mar 31, 2018 | 17.72 Mn |
| Dec 31, 2017 | 22.86 Mn |
| Sep 30, 2017 | 21.48 Mn |
| Jun 30, 2017 | 24.32 Mn |
| Mar 31, 2017 | 25.27 Mn |
| Dec 31, 2016 | 31.76 Mn |
| Sep 30, 2016 | 20.82 Mn |
| Jun 30, 2016 | 24.64 Mn |
| Mar 31, 2016 | 31.10 Mn |
| Dec 31, 2015 | 25.57 Mn |
| Sep 30, 2015 | 32.97 Mn |
| Jun 30, 2015 | 39.12 Mn |
| Dec 31, 2014 | 47.67 Mn |
| Sep 30, 2014 | 53.18 Mn |
| Dec 31, 2013 | 11.06 Mn |